Diabetes i sig är ingen riskfaktor för COVID-19 (Corona), varken för barn eller vuxna


  • VUXNA.
  • Har personer med diabetes ett nedsatt immunförsvar? Svaret är nej

Frågan diskuteras utförligt med 40 referenser av hans Jönsson, vetenskaplig journalist.

Nedtill finns genomgång, överst ligger text på engelska och nedanför den svenska texten, menmed samma innehåll


  • American Diabetes Association (ADA) har diskuterat samma fråga med samma svar. Nej


We know you have questions. We have the answers.

  • Are people with diabetes more likely to get COVID-19?

People with diabetes are NOT more likely to get COVID-19 than the general population. The problem people with diabetes face is primarily a problem of worse outcomes, not greater chance of contracting the virus. In China, where most cases have occurred so far, people with diabetes had much higher rates of serious complications and death than people without diabetes—and generally we believe that the more health conditions someone has (for example, diabetes and heart disease), the higher their chance of getting serious complications from COVID-19. While the death toll is likely to rise as the virus spreads, we expect the death rate—the number of people who die from the virus as a percentage of the total number of people who contract the virus—to go down as we get better at detecting and treating this specific virus.



  • Do people with diabetes have a higher chance of experiencing serious complications from COVID-19?
  • Do I need to worry about DKA (diabetic ketoacidosis)?
  • Is COVID-19 different from the seasonal flu?
  • What are the symptoms and warning signs I should be watching out for—and what do I do if I think I’m developing them?
  • What are the emergency warning signs—and what should I do if I’m experiencing them?
  • Are the risks different for people with type 1 and type 2 diabetes?
  • What should I do to prevent the spread of COVID-19 in my home—and what do I do if someone in my household has the virus?
  • Will COVID-19 impact my access to insulin and other diabetes supplies?
  • European Association for the Study of Diabetes (EASD) svarar också på frågan nej

• International Society for Pediatric and Adolscent Diabetes (ISPAD) svarar också nej


  • Prof Jonas Ludvigsson, Karolinska Institutet i Stockholm har gjort en färsk review publicerad idag, Systematic review of COVID-19 in children show milder cases and a better prognosis than adults


Abstract from docwire



The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognoses in children are rare.


A systematic literature review was carried out to identify papers on COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), using the Medline and EMBASE databases between 1 January and 18 March 2020.


The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1-5% of diagnosed COVID-19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID-19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances.


COVID-19 has occurred in children, but they seemed to have a milder disease course and better prognoses than adults. Deaths were extremely rare.


• The coronavirus disease 2019 (COVID-19) pandemic has affected hundreds of thousands of

people worldwide, but data on how it affects children are rare.

• A systematic literature review identified 45 papers and letters published up to 18 March

and this showed that children have so far accounted for 1-5% of diagnosed cases.

• Children often have milder disease than adults, and deaths have been extremely rare.


In conclusion, this review identified 45 relevant studies on COVID-19 in children and the majority of the data were from China. Many of these studies seemed to overlap, with regards to the data they presented, and some of the children who were diagnosed with COVID-19 did not have their diagnoses verified by laboratory tests. This has implications for prognoses. For example, Dong et al found that children with suspected COVID-19 had more severe disease than those with laboratory-confirmed disease. This suggests that a number of suspected COVID-19 cases may have been caused by other pathogens14, and it may still be too early to conclude that young children have a more severe COVID-19 than older children.

Our key findings were that the disease course in paediatric COVID-19 was milder than in adults, children had a better prognosis and deaths were extremely rare.



www red DiabetologNytt